Moderate To Severe Pain clinical trials

Explore recruiting moderate to severe pain clinical trials.

Recruiting moderate to severe pain studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Moderate To Severe Pain trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Open-label, prospective study to assess the safety, tolerability, analgesic effect and feasibility of IN SUF/KET in pediatric patients with moderate or severe pain, in an acute care setting

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

First administration of a single and increasing doses of BDT272 to assess its safety and pharmacokinetic in healthy volunteers

France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Multinational, multicentre, double-blind study to evaluate the efficacy and safety of bovine chondroitin sulfate 800 mg tablets versus marine chondroitin sulfate 800 mg tablets in the treatment of pain and functional impairment due to knee osteoarthritis

Czechia, Hungary, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A single-arm, open-label, Phase III trial to evaluate the safety and tolerability of intra-articular injections of RTX-GRT7039 in subjects with moderate to severe pain associated with osteoarthritis of the knee.

Romania, Bulgaria, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A blinded randomized study investigating the effect of pericapsular nerve group (PENG) block on postoperative pain after peri-acetabular osteotomy

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

A multicentre randomized, double-blind, placebo-controlled, dose-finding, Phase 2 study (MARS-17) of GSK3858279 in adult participants with moderate to severe pain due to knee osteoarthritis.

Germany, France, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Moderate To Severe Pain trials by city

Moderate To Severe Pain in Toronto Moderate To Severe Pain in Vancouver Moderate To Severe Pain in Montreal Moderate To Severe Pain in Calgary Moderate To Severe Pain in Edmonton Moderate To Severe Pain in Ottawa Moderate To Severe Pain in Winnipeg Moderate To Severe Pain in Quebec City Moderate To Severe Pain in Hamilton Moderate To Severe Pain in Kitchener Moderate To Severe Pain in London Moderate To Severe Pain in Halifax Moderate To Severe Pain in New York Moderate To Severe Pain in Los Angeles Moderate To Severe Pain in Chicago Moderate To Severe Pain in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease